Mirza Mansoor Raza
Insider CIK 1588389 · KPTI Director · SERA Director · ACRV Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SERA SERA PROGNOSTICS, INC. | A Award deriv | 2026-07-10 | 2026-07-14 | 2,725 | — | $0 | 2,725 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award deriv | 2026-07-10 | 2026-07-14 | 34,494 | — | $0 | 34,494 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award | 2026-07-10 | 2026-07-14 | 22,426 | — | $0 | 80,166 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award | 2026-07-10 | 2026-07-14 | 1,771 | — | $0 | 81,937 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award | 2026-05-18 | 2026-05-20 | 38,817 | — | $0 | 38,817 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2026-03-01 | 2026-03-03 | 174,068 | — | $0 | 174,068 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2025-12-05 | 2025-12-05 | 292 | $3.05 | $891 | 57,740 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2025-11-05 | 2025-11-06 | 221 | $3.04 | $672 | 58,032 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2025-10-06 | 2025-10-06 | 227 | $3.16 | $717 | 58,253 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2025-10-01 | 2025-10-03 | 225,000 | — | $0 | 225,000 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2025-09-05 | 2025-09-05 | 222 | $3.35 | $744 | 58,480 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2025-08-05 | 2025-08-05 | 225 | $2.50 | $563 | 58,702 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2025-07-07 | 2025-07-08 | 234 | $2.36 | $552 | 58,927 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2025-06-06 | 2025-06-06 | 107 | $1.58 | $169 | 59,161 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award deriv | 2025-06-05 | 2025-06-06 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award | 2025-06-05 | 2025-06-06 | 15,596 | — | $0 | 59,268 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2025-05-28 | 2025-05-29 | 4,600 | — | $0 | 4,600 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2025-05-08 | 2025-05-09 | 106 | $2.44 | $259 | 43,672 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2025-04-07 | 2025-04-08 | 107 | $3.35 | $358 | 43,778 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2025-03-06 | 2025-03-07 | 99 | $4.16 | $412 | 43,885 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2025-02-12 | 2025-02-14 | 101 | $4.58 | $463 | 43,984 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | M Exercise deriv | 2025-01-27 | 2025-01-27 | 37,549 | — | $0 | 0 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | M Exercise | 2025-01-27 | 2025-01-27 | 37,549 | $0.91 | $34.2K | 44,085 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2025-01-06 | 2025-01-07 | 100 | $7.69 | $769 | 6,536 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2024-12-06 | 2024-12-09 | 93 | $7.12 | $662 | 6,636 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2024-11-11 | 2024-11-12 | 95 | $7.32 | $695 | 6,729 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2024-10-07 | 2024-10-07 | 96 | $7.15 | $686 | 6,824 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2024-09-06 | 2024-09-09 | 96 | $7.16 | $687 | 6,920 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | S Sale | 2024-08-07 | 2024-08-08 | 101 | $7.42 | $749 | 7,016 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award deriv | 2024-06-06 | 2024-06-07 | 10,549 | — | $0 | 10,549 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award | 2024-06-06 | 2024-06-07 | 7,117 | — | $0 | 7,117 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2024-05-29 | 2024-05-30 | 69,000 | — | $0 | 69,000 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award deriv | 2023-06-08 | 2023-07-07 | 63,265 | — | $0 | 63,265 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2023-05-24 | 2023-05-25 | 34,000 | — | $0 | 34,000 | SEC↗ |
| SERA SERA PROGNOSTICS, INC. | A Award deriv | 2022-06-03 | 2022-06-06 | 149,675 | — | $0 | 149,675 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2022-05-19 | 2022-05-20 | 23,900 | — | $0 | 23,900 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2021-05-21 | 2021-05-21 | 23,900 | — | $0 | 23,900 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-12-18 | 2020-12-22 | 5,000 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-12-18 | 2020-12-22 | 5,000 | $5.43 | $27.1K | 5,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-12-18 | 2020-12-22 | 5,000 | $18.00 | $90.0K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-12-07 | 2020-12-08 | 20,000 | — | $0 | 5,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-12-07 | 2020-12-08 | 5,000 | $16.14 | $80.7K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-12-07 | 2020-12-08 | 5,000 | $16.04 | $80.2K | 5,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-12-07 | 2020-12-08 | 5,000 | $16.05 | $80.3K | 10,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-12-07 | 2020-12-08 | 5,000 | $16.05 | $80.3K | 15,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-12-07 | 2020-12-08 | 20,000 | $5.43 | $108.6K | 20,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-05-21 | 2020-05-26 | 16,400 | — | $0 | 16,400 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-03-02 | 2020-03-04 | 5,000 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-03-02 | 2020-03-04 | 5,000 | $23.50 | $117.5K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-03-02 | 2020-03-04 | 5,000 | $8.06 | $40.3K | 5,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-01-09 | 2020-01-13 | 2,056 | — | $0 | 5,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-01-09 | 2020-01-13 | 2,056 | $20.00 | $41.1K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-01-09 | 2020-01-13 | 2,056 | $8.06 | $16.6K | 2,056 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2019-12-27 | 2019-12-31 | 2,944 | — | $0 | 7,056 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-12-27 | 2019-12-31 | 2,944 | $20.00 | $58.9K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2019-12-27 | 2019-12-31 | 2,944 | $8.06 | $23.7K | 2,944 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2019-12-18 | 2019-12-20 | 12,121 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2019-12-18 | 2019-12-20 | 12,121 | $1.49 | $18.1K | 12,121 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-12-18 | 2019-12-20 | 7,121 | $17.18 | $122.3K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-12-18 | 2019-12-20 | 5,000 | $17.18 | $85.9K | 7,121 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2019-12-09 | 2019-12-11 | 10,342 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2019-12-09 | 2019-12-11 | 10,342 | $5.64 | $58.3K | 10,342 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-12-09 | 2019-12-11 | 5,342 | $17.02 | $90.9K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-12-09 | 2019-12-11 | 5,000 | $17.02 | $85.1K | 5,342 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2019-06-06 | 2019-06-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-08-30 | 2018-09-04 | 2,236 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-08-30 | 2018-09-04 | 264 | — | $0 | 10,342 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-08-30 | 2018-09-04 | 2,236 | $1.49 | $3.3K | 2,236 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-08-30 | 2018-09-04 | 2,500 | $21.00 | $52.5K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-08-30 | 2018-09-04 | 264 | $5.64 | $1.5K | 264 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-08-29 | 2018-08-30 | 2,500 | — | $0 | 2,236 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-08-29 | 2018-08-30 | 2,500 | $20.00 | $50.0K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-08-29 | 2018-08-30 | 2,500 | $1.49 | $3.7K | 2,500 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2018-06-19 | 2018-06-20 | 17,000 | — | $0 | 17,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-05-10 | 2018-05-11 | 1,325 | — | $0 | 4,736 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-05-10 | 2018-05-11 | 675 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-05-10 | 2018-05-11 | 675 | $0.26 | $176 | 675 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-05-10 | 2018-05-11 | 2,000 | $18.00 | $36.0K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-05-10 | 2018-05-11 | 1,325 | $1.49 | $2.0K | 1,325 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-03-12 | 2018-03-14 | 2,500 | — | $0 | 675 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-03-12 | 2018-03-14 | 2,500 | $0.26 | $650 | 2,500 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-03-12 | 2018-03-14 | 2,500 | $17.01 | $42.5K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-03-05 | 2018-03-06 | 2,500 | — | $0 | 3,175 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-03-05 | 2018-03-06 | 2,500 | $0.26 | $650 | 2,500 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-03-05 | 2018-03-06 | 2,500 | $16.00 | $40.0K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-02-08 | 2018-02-12 | 1,500 | — | $0 | 5,675 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-02-08 | 2018-02-12 | 1,500 | $0.26 | $390 | 1,500 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-02-08 | 2018-02-12 | 1,500 | $14.00 | $21.0K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-02-07 | 2018-02-08 | 1,099 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-02-07 | 2018-02-08 | 401 | — | $0 | 7,175 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-02-07 | 2018-02-08 | 1,099 | $0.26 | $286 | 1,099 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-02-07 | 2018-02-08 | 1,500 | $13.00 | $19.5K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-02-07 | 2018-02-08 | 401 | $0.26 | $104 | 1,500 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2017-10-02 | 2017-10-04 | 2,000 | — | $0 | 1,099 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2017-10-02 | 2017-10-04 | 2,000 | $0.26 | $520 | 2,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2017-10-02 | 2017-10-04 | 2,000 | $12.00 | $24.0K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2017-09-15 | 2017-09-18 | 2,882 | — | $0 | 3,099 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2017-09-15 | 2017-09-18 | 2,882 | $0.26 | $749 | 2,882 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2017-09-15 | 2017-09-18 | 2,882 | $11.00 | $31.7K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2017-09-11 | 2017-09-13 | 118 | — | $0 | 5,981 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2017-09-11 | 2017-09-13 | 118 | $0.26 | $31 | 118 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2017-09-11 | 2017-09-13 | 118 | $11.00 | $1.3K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2017-06-15 | 2017-06-16 | 17,000 | — | $0 | 17,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2016-06-16 | 2016-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2015-12-08 | 2015-12-10 | 2,556 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2015-12-08 | 2015-12-10 | 6,061 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2015-12-08 | 2015-12-10 | 2,121 | — | $0 | 6,099 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2015-12-08 | 2015-12-10 | 2,121 | $0.26 | $551 | 6,383 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2015-12-08 | 2015-12-10 | 2,556 | $0.03 | $77 | 6,818 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2015-12-08 | 2015-12-10 | 2,556 | $15.01 | $38.4K | 4,262 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2015-12-08 | 2015-12-10 | 6,061 | $0.03 | $182 | 10,323 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2015-12-08 | 2015-12-10 | 6,061 | $15.01 | $91.0K | 4,262 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2015-12-08 | 2015-12-10 | 6,383 | $15.01 | $95.8K | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2015-05-22 | 2015-05-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2014-12-02 | 2014-12-03 | 5,000 | — | $0 | 2,555 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2014-12-02 | 2014-12-03 | 5,000 | $0.03 | $150 | 9,262 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2014-12-02 | 2014-12-03 | 5,000 | $45.18 | $225.9K | 4,262 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2014-12-01 | 2014-12-03 | 1,535 | — | $0 | 7,555 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2014-12-01 | 2014-12-03 | 5,000 | $41.86 | $209.3K | 4,262 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2014-12-01 | 2014-12-03 | 1,535 | $0.03 | $46 | 9,262 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2014-11-10 | 2014-11-12 | 5,000 | $45.05 | $225.3K | 7,727 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2014-11-03 | 2014-11-05 | 5,000 | $40.95 | $204.8K | 12,727 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2014-10-29 | 2014-10-31 | 3,500 | $40.05 | $140.2K | 17,727 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2014-10-20 | 2014-10-22 | 1,500 | $35.04 | $52.6K | 21,227 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2014-07-08 | 2014-07-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2013-12-18 | 2013-12-20 | 15,000 | — | $0 | 15,000 | SEC↗ |